The rounds this investor is named on, who it invests beside, and where it shows up.
Named on one round in the feed.
Vestal Point Capital is an investment firm specializing in the life sciences. We manage a diverse portfolio of securities across the biotechnology, pharmaceuticals, medical devices, tools, and diagnostics sectors.
Venture capitalNew York, NY 10012vestalpoint.comSince 2026-11-09
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Delix Therapeutics A clinical-stage neuroscience company pioneering the discovery and development of neuroplastogens | Series C Verified against 1 of 2 sources | $100M | 2026-11-09 | [ PART ] |